Bliss GVS Pharma Investor Relations Material
Latest events
Q4 24/25
2 May, 2025
Q3 24/25
28 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bliss GVS Pharma Limited
Access all reports
Bliss GVS Pharma Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company offers dosage forms including suppositories, tablets, capsules, dry syrups, creams, and ointments across therapeutic segments such as anti-malarial, dermatology, gynecology, and anti-infectives. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
506197
Country
🇮🇳 India